CAPTRUST Financial Advisors’s Collegium Pharmaceutical COLL Stock Holding History

CAPTRUST Financial Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18,234	Closed	-$561K	–	2258
2023 Q4	$561K	Sell	18,234 -12,319	-40%	-$309K	﹤0.01%	1661
2023 Q3	$683K	Sell	30,553 -14,774	-33%	-$337K	﹤0.01%	1434
2023 Q2	$974K	Buy	+45,327	New	+$1.03M	﹤0.01%	1220
2022 Q3	–	Sell	-921	Closed	-$16K	–	2450
2022 Q2	$16K	Sell	921 -1,230	-57%	-$20.7K	﹤0.01%	3486
2022 Q1	$44K	Buy	2,151 +1,062	+98%	+$20.1K	﹤0.01%	2872
2021 Q4	$20K	Sell	1,089 -33	-3%	-$643	﹤0.01%	3276
2021 Q3	$22K	Sell	1,122 -73	-6%	-$1.58K	﹤0.01%	3084
2021 Q2	$28K	Buy	1,195 +73	+7%	+$1.69K	﹤0.01%	2880
2021 Q1	$27K	Buy	+1,122	New	+$26.7K	﹤0.01%	2810

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CAPTRUST Financial Advisors's COLL Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of Collegium Pharmaceutical (COLL) in Q1 2024, closing a stake of 18,234 shares — an estimated $561K sold.

CAPTRUST Financial Advisors first reported a position in COLL in Q1 2021 and held it in 9 quarters. The position peaked at $974K in Q2 2023. 228 funds tracked by Wall St. Rank hold COLL as of Q1 2024.

CAPTRUST Financial Advisors reported no remaining Collegium Pharmaceutical position as of Q1 2024 after selling out during the quarter.
CAPTRUST Financial Advisors sold 18,234 Collegium Pharmaceutical shares in Q1 2024, an estimated $561K.
CAPTRUST Financial Advisors first reported a position in Collegium Pharmaceutical in Q1 2021 and held it in 9 quarters.
CAPTRUST Financial Advisors's Collegium Pharmaceutical position peaked at $974K in Q2 2023.
228 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.